Results 151 to 160 of about 8,114 (293)

Unfolding the rarity of SMARCA4 deficient uterine sarcoma (SDUS): A case report

open access: gold, 2021
Annie Kanchan Baa   +4 more
openalex   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony‐Stimulating Factor‐1 Receptor‐Related Disorders

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela   +13 more
wiley   +1 more source

The rarity of Petit's hernia: A case report on diagnosis and treatment

open access: gold, 2023
Mauricio Muñoz-Muñoz   +2 more
openalex   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer   +14 more
wiley   +1 more source

Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte   +13 more
wiley   +1 more source

Friends of Musselman LIbrary Newsletter Spring 2008

open access: yes, 2008
Table of Contents: From the Director: Honor with Books Kick-Off (Robin Wagner, Brittany Bloam ’07, Jack Ryan, Robert Bohrer); Library Helps Information Literacy (Katherine Downton); Save the Date: Piano Trio; Library Lingo (Kathy D’Angelo); Federated ...
Musselman Library,
core  

Paraganglioma of urinary bladder, an innocent rarity or a nightmare: A case series report and review [PDF]

open access: diamond, 2023
Vivek Mahadeo Barekar   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy